In a major twist in global health cooperation, BRICS is gearing up to tackle tuberculosis (TB) with renewed vigor in 2025! 🚀 This dynamic bloc, responsible for over 50% of global TB cases, is combining innovative ideas and research for a healthier future.
At the 18th BRICS Tuberculosis Research Network meeting in May, experts explored advances in TB prevention, diagnosis, vaccines, and treatment. The discussion focused on how expanded partnerships can fast-track the development of new vaccines and faster treatment options. This collaborative spirit could change the way TB is fought worldwide.
Every year, 10 million people fall ill with TB, and in 2023 the World Health Organization reported 1.25 million deaths. Although TB is preventable and curable, it remains the deadliest infectious disease. Most patients are in low- and middle-income regions, with nearly half of TB cases reported in India, Indonesia, the Chinese mainland, the Philippines, and Pakistan.
Treatment usually involves a six-month antibiotic course, but drug-resistant TB poses extra challenges, often requiring longer and more complex care. The WHO's End TB Strategy aims to eliminate the disease as a public health threat by 2035, even as funding has dipped from $6.8 billion in 2019 to $5.7 billion in 2023.
This bold initiative by BRICS nations promises a reshaped global health paradigm, inspiring hope in the battle against TB. Stay tuned as these passionate leaders forge new paths toward ending the epidemic. 💪🌍
Reference(s):
BRICS reshape paradigm for global health cooperation in ending TB
cgtn.com
